Optical sensors are demonstrating the largest potential for Lab-on-a-chip (LOC) systems to perform sensitive, quantitative, and fast sensing for healthcare and environmental monitoring. Among all options, biosensors based on refractometric sensing schemes combine high sensitivity with label-free detection, however, most of them still have not yet been miniaturized in LOC devices for the analysis of biological targets. Here, we demonstrate for the first time a fully miniaturized optical biosensor based on plasmonic-sensing that enables quantitative detection of biological analytes that are potentially found in milk (lactoferrin, streptomycin). The sensor relies on the unprecedented combination of i) miniaturized, monolithically integrated, and cost-effective optical transduction elements such as organic light-emitting diodes and organic photodiodes, and ii) immunoassay-based bio-recognition elements, for highly sensitive and specific localized surface plasmon resonance (LSPR) based detection via a nanostructured plasmonic grating. The sensor is also equipped with portable read-out electronics and microfluidic circuitry, allowing fast, reproducible and reliable functioning. The quantitative response is calibrated through reference samples and it allows reaching a limit of detection of 10-4 refractive index units (RIU) as LSPR sensor. The quantitative and analyte-specific detection is demonstrated for lactoferrin in the laboratory, giving a sensitivity as low as 9 ug/mL. The presented work opens the way for the universal application of optical biosensors in LOC devices, for on-site food analysis, and health monitoring, among others.
This work received funding from the European Union's Horizon 2020 research and
innovation programme under grant agreement no. 780839 (MOLOKO) and no. 101016706 (h-ALO).
The integration of multiple devices in a single functional unit is boosting the advent of a series of compact optical sensors for rapid and on-site analysis. In this context, the huge potential of plasmonic-based sensors has been affected by the strict constraints of the detection scheme. The need for laboratory equipment, such as laser sources and expensive prism-based optics, results therefore in not-portable systems.
Here, an ultra-compact plasmonic sensor is demonstrated through the smart-integration of an organic light-emitting transistor (OLET), an organic photodiode (OPD), and a nanostructured plasmonic grating (NPG).[1] The direct integration of the OPD onto the planar structure of the OLET provided an unprecedented high degree of proximity of the light-source and light detecting areas, which enabled the exploitation of the angle-dependent sensing characteristics of the NPG.
The most effective 3D layout of integration, including the optimal size and relative positioning of the three elements (i.e. OLET, OPD, and NPG), was unravelled by an advanced simulation tool, which also predicted the signal variation of the sensor under different conditions. Accordingly, the effectiveness of the new plasmonic-based detection scheme was demonstrated by the dependence of the OPD photocurrent on the surrounding environment of the NPG. In particular, a variation of the OPD photocurrent of about 10-9 A was recorded when exposing the NPG from water to alcoholic solutions at different concentrations.
A miniaturized plasmonic sensor with a total size of 0.1 cm3 was therefore obtained through the smart integration of nanometer-thick optoelectronic and plasmonic components.
[1] M. Prosa, et. al. Adv. Funct. Mater. 2021, 2104927. https://doi.org/10.1002/adfm.202104927
Chronic wounds represent a significant burden to patients, health care professionals, and health care systems, affecting over 40 million patients and creating costs of approximately 40 billion € annually. We will present a medical device for photo-stimulated wound care based on a wearable large area flexible and disposable light management system consisting of a waveguide with incorporated micro- and nanometer scale optical structures for efficient light in-coupling, waveguiding and homogeneous illumination of large area wounds. The working principle of this innovative device is based on the therapeutic effects of visible light to facilitate the self-healing process of chronic wounds. On the one hand, light exposure in the red (656nm) induces growth of keratinocytes and fibroblasts in deeper layers of the skin. On the other hand, blue light (453nm) is known to have antibacterial effects predominately at the surface layers of the skin. In order to be compliant with medical requirements the system will consist of two elements: a disposable wound dressing with embedded flexible optical waveguides for the light management and illumination of the wound area, and a non-disposable compact module containing the light sources, a controller, a rechargeable battery, and a data transmission unit. In particular, we will report on the developed light management system. Finally, as a proof-of-concept, a demonstrator will be presented and its performances will be reported to demonstrate the potential of this innovative device.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.